de Jong, P H <br/><br/>
Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trial.  [electronic resource] 

 -  Annals of the rheumatic diseases  Jan 2013 
 - 72-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1468-2060 
<br/><br/><label>Standard No.: </label>10.1136/annrheumdis-2011-201162  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Antirheumatic Agents--administration & dosage<br/>Arthritis, Rheumatoid--drug therapy<br/>Drug Therapy, Combination<br/>Female<br/>Glucocorticoids--administration & dosage<br/>Humans<br/>Hydroxychloroquine--administration & dosage<br/>Induction Chemotherapy<br/>Injections, Intramuscular<br/>Male<br/>Methotrexate--administration & dosage<br/>Middle Aged<br/>Recovery of Function--drug effects<br/>Sulfasalazine--administration & dosage